• Knightscope is building a clientele for its robotic security force models, including about dozens of clients from Fortune 1000 companies, to law enforcement agencies, hospitals, casinos, water utilities, malls and manufacturing plants
• The company’s robots use artificial intelligence to navigate indoor and outdoor areas that are Americans with Disabilities Act compliant, and can be monitored with a simple browser and Internet connection
• The robots record data and use recognition features to assess potentially significant elements such as human activities, thermal changes and license plate information
• The privately held company is backed by more than 16,000 investors and four major corporations, and has raised more than $70 million since its founding in 2013
• Knightscope has now secured its first agreement with the federal government for a project at a Texas Veterans Administration hospital, which the company hopes may lead to more federal projects in the future

A series of publicized incidents in which police officers used violence against racial minorities during the past few years, generating controversy because of their tactics, has led to a nationwide debate about the role of law enforcement and the potential need for police reform. The debate has extended beyond the purview of street-patrolling officers in metropolitan areas, as demonstrated by the recent announcement from the University of Oregon that it will convert several vacant armed police officer positions into frontline, unarmed community service officer positions — an effort to develop more confidence in campus security forces while retaining a backup armed police presence for potentially violent circumstances (https://ibn.fm/9I0id). Autonomous Security Robot developer Knightscope is pursuing a distinct strategy for generating confidence in protective forces. The company’s roving, artificial intelligence-equipped sentries are designed to create a qualified security presence not unlike the one used at the university, presenting a non-threatening patrol that is nonetheless a capable, critical frontline deployment in combating criminal forces. Knightscope’s indoor and outdoor-capable models feature 360-degree eye-level HD streaming video, speakers for recorded or live communication, and recognition features that detect people, faces, license plates, thermal fluctuations and automatic signals. A whimsical CG-animated video of the robots arriving at a train station celebrates the company’s first deployment on behalf of the federal government with an agreement to use them at the Audie L. Murphy Memorial Veteran’s Hospital in San Antonio, Texas (https://ibn.fm/Y7PiG). Knightscope is hopeful its performance there will lead to additional government projects in the future. “One of the more obvious roles for robots in security is that they’re highly productive in repetitive and dangerous tasks,” Stacy Stephens, the vice president of marketing and sales, said in another video that explains how the robots work (https://ibn.fm/KeRYE). “So if you can imagine putting a human being into a place where they’re doing the same thing over and over and over again, they become ineffective very, very quickly. You can also imagine having to put somebody in the line of fire in a dangerous situation — a robot doesn’t care about that. You put them in there instead of a human being, you make it safer and much more productive.” Human operators can then monitor and review the data the sentries collect at will. The robots function in Americans with Disabilities Act-compliant areas, using LiDAR for navigation in combination with sonar and GPS to navigate. They also retain video data for two weeks, which is accessible with a simple Chrome browser and Internet connection. Their mere presence may serve as a deterrent for problems. The company estimates that the robots operate in a price range of about $4 to $11 an hour, which makes their service less expensive than their human counterparts after they’ve been purchased. Clients include about Fortune 1000 clients, such as Samsung and Citizens Bank, five major hospitals plus law enforcement agencies. Using equity crowdfunding, Knightscope has raised millions of dollars to support its operations from a larger pool than most big money companies might seek and is now raising growth capital to scale up its operations. “A lot of larger institutional investors will say, … ‘You have 7,000 investors, they must be driving you mad,’” CEO William Santana Li said during an interview earlier this year with StartEngine strategic adviser Kevin O’Leary, aka Mr. Wonderful (https://ibn.fm/iYrcV). “I tell them, ‘Listen, chief security officers of major corporations are investors of ours. NYPD detectives, FBI, CIA, DHS, vice presidents of leasing of major malls. I would never dare trade out our 7,000 investors for three or four guys (it’s mostly guys) sitting around a table asking the wrong questions, worried about all the wrong things.” Knightscope is now backed by more than 16,000 investors and four major corporations, having raised more than $70 million since it began in 2013. For more information, visit the company’s website at www.Knightscope.com. Visit www.Knightscope.com/Invest for a summary of Knightscope as an investment, with a blue Instant Messaging button for direct contact with their CEO. NOTE TO INVESTORS: The latest news and updates relating to Knightscope are available in the company’s newsroom at https://ibn.fm/Knight

• CEO expects results that will “build the stock and raise the stock price”
• POAI focused on positioning TumorGenesis kits to manufacturers
• Helomics has largest database of its kind in the world, brings cutting-edge technology to cancer research

During a recent NetworkNewsWire exclusive audio interview, Predictive Oncology (NASDAQ: POAI) CEO Carl Schwartz noted recent company milestones and outlined strategic goals. In addition, Schwartz provided key updates on the company’s four impressive subsidiaries: Skyline Medical, TumorGenesis, Soluble Biotech and Helomics. “I’m very encouraged. I think we’re moving right along. Things never go as fast as we would like them, and it can be very frustrating at times,” Schwartz stated. “We have a lot going on, and we’re working hard on our goals. . . . We expect results that will be advantageous to the company and that will build the stock and raise the stock price.” During the interview, Schwartz noted that the original purpose of TumorGenesis was to develop a lab media to replace rats and mice in scientific industries as well as the testing of tumors. The company has succeeded in developing the first media: ovarian cancer. “This media, which, as I said, replicates the body, fools the tumor into thinking it’s still in the body,” Schwartz explained. “Its reactions are very, very similar to what it would have done had it been in the body. Now the next step is to get it positioned to manufacturers and getting the kits out so people can use it. That’s coming along handsomely.” Schwartz also talked about POAI’s newest subsidiary, Soluble Biotech, which is essentially the combination of two labs. “We moved them now into a research park,” he said. “We quadrupled the space that they have, and they have the latest in equipment. The technology used by Soluble is proprietary. These machines that we have were developed some time ago and are the only machines of their kind. In the determination of solubility of products, they work wonders in that area. We expect, going forward, that they’ll get a number of contracts.” Finally, Schwartz noted that POAI has positioned Helomics to compete in the marketplace. “The original basis of Helomics . . . was that physicians or hospitals would send their tumors to this company, and they would test the tumors with the known therapies of the day,” he said. “In that process, [Helomics] accumulated over 150,000 tumors covering over 137 different cancer.” Schwartz noted that Helomics currently has the largest database of its kind in the world, and through its subsidiary, POAI brings cutting-edge technology to cancer research and works with the pharmaceutical, diagnostic and biotech industries to develop predictive models of how specific tumors may respond. “With that data, and the fact that we’ve sequenced these tumors, we have shown that we can provide quality information to anyone who needs it,” he continued. “There’s a lot going on at Helomics. We think we’ve validated the company. We’ve got assets that are one-of-a-kind in the world, and we think we are on our way to where we wanted to be when we first purchased this company a couple of years ago.” Predictive Oncology operates through three segments (domestic, international and other), which contain four subsidiaries; Helomics, TumorGenesis, Skyline Medical and Skyline Europe. Helomics applies artificial intelligence to its rich data gathered from patient tumors to both personalize cancer therapies for patients and drive the development of new targeted therapies in collaborations with pharmaceutical companies. Helomics’ CLIA-certified lab provides clinical testing that assists oncologists in individualizing patient treatment decisions by providing an evidence-based road map for therapy. In addition to its proprietary precision oncology platform, Helomics offers boutique CRO services that leverage its TruTumor(TM), patient-derived tumor models coupled to a wide range of multi-omics assays (genomics, proteomics and biochemical), and an AI-powered proprietary bioinformatics platform to provide a tailored solution to its clients’ specific needs. Predictive Oncology’s Skyline Medical division markets its patented and FDA-cleared STREAMWAY System, which automates the collection, measurement and disposal of waste fluid, including blood, irrigation fluid and others, within a medical facility, through both domestic and international divisions. The company has achieved sales in five of the seven continents through both direct sales and distributor partners. For more information, visit the company’s website at www.Predictive-Oncology.com NOTE TO INVESTORS: The latest news and updates relating to POAI are available in the company’s newsroom at http://ibn.fm/POAI

• Subsidiary InsuraGuest Insurance Agency, LLC, is now licensed to offer surplus lines of casualty and property insurance in the state of Utah
• This licensing allows for more markets and additional products to be sold, which generates additional revenue and caters to InsuraGuest’s expansion goals in the insurance marketplace
• Company now offers its products and services throughout the United States in their entirety
• Surplus lines insurance market is expected to reach $125.9 billion by 2027

InsuraGuest Technologies (TSX.V: ISGI) (OTC: IGSTF), a leader in the insurtech industry, now offers its insurance services and products nationwide and has gained access to more markets and revenue streams after being approved as a resident surplus lines producer, receiving a license to offer surplus lines casualty and surplus lines property insurance in the state of Utah. In a November 5, 2020 press release announcing the pivotal moment, InsuraGuest said the license was granted to its wholly owned subsidiary InsuraGuest Insurance Agency, LLC (IG Agency). As a result, IG Agency can now sell other non-admitted insurance products, as well as be listed as official producer for InsuraGuest’s Hospitality Liability Master Policy on all certificates issued to hotels and vacation rentals (https://ibn.fm/eAXw5). Surplus lines insurance protects against a financial risk that is too high for a regular insurance company to take on. Reasons that a company may require surplus lines insurance include:

• Poor loss history
• Business operations are unusual, hazardous, or difficult to assess the true risk – environmental cleanup, wind farms, amusement parks
• The necessity for coverages not offered by standard insurers
• Beginning a new venture or starting a higher risk business
• The necessity for higher limits or broader coverage than insurers are willing to provide

The insurance market changes rapidly, which pushes standard insurers to reassess risk and liability. They may suddenly refuse to insure the same types of risks they did weeks ago. That is where surplus lines insurance steps in to protect those needing insured (https://ibn.fm/bTPni). The market size for surplus lines insurance in the US was valued at $52.1 billion in 2019. By 2027, it is expected to reach $125.9 billion growing at a CAGR of 15.2% from 2020 to 2027. While already covering nontraditional needs, surplus lines insurance can also provide coverage for other industry sectors such as healthcare, construction, environmental, energy, and many other non-conventional services (https://ibn.fm/q9eWg). The licensing will allow InsuraGuest to capitalize on this insurance sector while also opening up more market opportunities to sell additional products and create more revenue streams. “We are very excited to now offer our products and services throughout the United States in their entirety,” said InsuraGuest CEO and Chairman Douglas Anderson. “We continue to expand and develop our product offerings to service our customers and build shareholder value, and the ability to provide true nationwide coverage marks a proud milestone for InsuraGuest.” InsuraGuest’s main goal is to disrupt the insurance landscape by utilizing its proprietary insurtech software platform to deliver digital insurance to multiple sectors. The company aims to transform the way insurance is delivered with the revolutionary idea that insurance should be bought, not sold. One of the sectors InsuraGuest is serving is the hospitality industry, where its proprietary insurtech platform integrates with approximately 70 different property management systems. The company’s Hospitality Liability Policy was designed to fill the gaps in other policies on the market, including a claims process that is easier to navigate. In addition, properties covered by the Hospitality Liability Policy can transfer certain liabilities to the InsuraGuest carrier, thus lowering their claim ratio and risk profile, as well as their general liability premiums. For more information, visit the company’s website at www.InsuraGuest.com. NOTE TO INVESTORS: The latest news and updates relating to ISGI are available in the company’s newsroom at http://ibn.fm/ISGI

• Survey suggest over 60% of millennials willing to accept lower returns if an investment is sustainable, 83% considering transitioning entire pension into sustainable portfolio
• SGTM produces environmentally beneficial products using natural waste created by hurricanes and storms while preventing burdens on municipal landfills
• SGTM recorded 794% increase in revenue and 4,817% increase in gross profit compared to all of 2019, preparing for future uplisting

Discretionary spending across almost all sectors has taken a dive in recent months as the global recession deepens. Despite the negative performance across many consumer goods and service sectors, some businesses continue to survive – and even thrive. Among them is Sustainable Green Team (OTC: SGTM), a leading provider of solutions for tree and storm waste disposal that turns problems into profits through the transformation of natural waste into products that benefit the environment. Awareness around sustainable investing appears to be increasing, particularly among millennials who appear to be driving the movement. A recent survey suggests that over 60% of investors within this age group would accept lower returns if an investment is ethical while 83% are considering transitioning their entire pension into a sustainable portfolio (https://ibn.fm/zDXtA). “You do not have to sacrifice returns when investing in a socially responsible portfolio,” said Jamie Broderick, Impact Investing Institute & former UK CEO of UBS Wealth Management. “There are several different categories along the spectrum of capital, and you can choose how you’d like to invest in line with your values, whether in line with market returns, or on a concessionary basis.” SGTM provides an opportunity for investors to take part in a sustainable business with significant growth potential. Through its subsidiaries, the company provides tree services that include debris hauling, debris removal, biomass recycling, mulch and playground surface material manufacturing, product packaging and sales. Founded in sustainability and based on vertically integrated operations, the company takes its role as a steward of the environment seriously by diverting this natural material from landfills and transforming it into a variety of organic, attractive, next-generation products that benefit the natural landscape. SGTM’s expansion plans include organic growth strategies, national partnerships and strategic acquisitions. Following a busy storm season that included Hurricane Laura relief efforts, the company was awarded a string of contracts with large companies that included The Kroger Co., Circle K, 7-Eleven, Old Castle Lawn & Garden, Menards Inc., and many more. The company has commenced the FORM-10 process to become fully reporting and, in anticipation of a future uplisting, disclosing a massive 794% increase in revenue and a 4,817% gross profit increase in the first half of 2020 when compared to all months in 2019 combined (https://ibn.fm/eL8dv). Along with its stellar financial results, SGTM’s impressive overall performance is a testament to the expertise of its management, bolstered by over 40 years of next-level experience across all the company’s verticals. It may not make front page news or create a buzz like electric vehicles or biotech innovation, but the work carried out by SGTM makes a positive impact that directly improve the lives of citizens in the communities the company serves – all while sharing the profits with its loyal group of investors. To learn more about Sustainable Green Team Ltd., view the investor presentation at https://ibn.fm/l1Pgk. NOTE TO INVESTORS: The latest news and updates relating to SGTM are available in the company’s newsroom at http://ibn.fm/SGTM

• Plant-based superfood developer Rritual Superfoods Inc. gained certification from the USDA validating its organic product marketing recently, helping to establish the company’s premium functional food elixirs following their launch in September
• The initial three product line elixirs, shots and mixes promote wellness by blending select nutraceutical mushrooms with adaptogenic roots to promote the body’s immune and cognitive function, as well as to reduce stress
• Market analysts predict the overall functional foods industry will achieve revenues of $268 billion by 2027
• Functional mushrooms are a still-emerging subsector within the industry, allowing Rritual opportunity to build a following from the ground floor within the marketplace

Therapeutic foods innovator Rritual Superfoods is gaining attention as it helps build the emerging new market for healthful mushroom elixirs as a beneficial superfood. On the heels of its initial product launch in September and an ECRM Buyer’s Choice Award last month for its attractive marketing and growing market presence (https://ibn.fm/mcl20), Rritual has secured organic certification from the U.S. Department of Agriculture (“USDA”), which provides “trusted, third-party validation of the quality of Rritual’s products” beyond the unregulated claims of many products to feature “all-natural” ingredients, CEO David Kerbel noted (https://ibn.fm/EVcx8). “We have a premium lineup that features powerful ingredients and with the addition of a Certified Organic seal our consumers can be confident they are making healthy, informed decisions about what they are putting in their body when they purchase Rritual,” Kerbel stated. Rritual was established earlier this year, amid the outsized health concerns accompanying a worldwide pandemic, with the purpose of helping to relieve stress, heighten cognitive function and boost the immune system through healthful elixirs, shots and mixes. The company’s initial product line features three select mushroom varieties that enjoy long-standing reputations for their beneficial biological properties. Each mushroom variety is teamed with natural “adaptogens” — herbal substances used to increase the body’s ability to resist biological stress (https://ibn.fm/EKakP). “The health and wellness benefits of mushrooms and plant-based therapies are backed by decades of scientific research. Rritual’s new line of elixirs embraces that research and provides consumers with an easy way to get a daily dose of the powerful effects,” Rritual President Dr. Mike Hart stated when the product lines were announced (https://ibn.fm/6IutV). The products will be available to consumers throughout North America during the first quarter of the new year, stepping back from the original announcement they’d be available in the fall. The elixirs and shots will be available in 14-stick packs and in 250-gram tubs, marketed at first through Rritual’s website and the company’s Amazon store before additional retail outlets are joined through the company team’s corporate connections. The blends include the Chaga mushroom paired with Eleuthero root to boost immunity, Lion’s Mane mushroom paired with Rhodiola root to support cognitive function and brain health, and Reishi mushroom paired with Ashwagandha root to help the body fight anxiety (https://ibn.fm/x3zAT). Each elixir also contains six other functional mushrooms as well as a prebiotic blend featuring inulin and lucuma fruit powder to support immune and digestive health. Analysts at Research And Markets forecast the overall functional foods industry will attain revenues of $268 billion by 2027 with a growth CAGR of 6.7 percent between 2021 and 2027, demonstrating the public’s interest in consuming highly nutritious foods even when many such products are expensive and may not have rigorous testing to underly their claims (https://ibn.fm/Km4qf). The emergence of the COVID-19 pandemic this year is seen as a significant driver in consumer interest toward functional foods. For more information, visit the company’s website at https://investors.WeAreRritual.com. “Mental Fitness is a Daily Ritual” NOTE TO INVESTORS:The latest news and updates relating to Rritual Mushrooms are available in the company’s newsroom at http://ibn.fm/Rritual

• Gage Cannabis, vertically integrated cannabis operator, has stated goals to become fastest-growing cannabis brand in state of Michigan
• Michigan’s cannabis industry has benefitted from strong growth momentum ever since state passed motion to legalize cannabis for adult recreational use in 2018; sector now valued at estimated $3 billion per annum at maturity
• Gage Cannabis currently has five retail locations across Michigan along with three wholly-owned cultivation centers all fully operational
• Company posted $13.1 million in 3Q2020 sales (unaudited), a 129% increase from its 1Q2020 figure of $5.8 million

On December 4, 2018, Michigan officially became the 10th state in the United States to legalize marijuana for adult recreational use. Since then, Gage Cannabis a leading vertically integrated operator in the cannabis industry led by former CEO and Chairman of Canopy Growth Corp. Bruce Linton, has sought to focus on the Michigan market, with the stated ambition of building the fastest-growing cannabis brand in the state. Gage Cannabis has witnessed a rapid growth trajectory since its inception, having opened its first medical provisioning center (dispensary) in the state of Michigan in 2019. Since then, the company has seen its retail footprint expand to five medical or adult-use locations, with plans to operate 20+ locations by the end of 2021. Gage Cannabis has simultaneously sought to complement its retail distribution network with a swiftly expanding cultivation operation—one which has focused on producing small-batch, indoor-grown, and hand-trimmed plants designed to ensure that every gram of cannabis sold is of the highest quality. Currently, the company boasts three operational cultivation sites, located at Monitor Township, Harrison Township, and Warren while operating one processing facility located in the Harrison Township. Going forward, the company intends to open a new processing facility located in close proximity to its cultivation assets. Ever since the use of recreational cannabis was legalized in 2018, Michigan has emerged as one of the fastest-growing legal cannabis markets in the United States in terms of consumption. State authorities have recently projected recreational marijuana sales to be worth nearly $1 billion per annum in 2021 with revenues set to rise above $1.5 billion by 2023 (https://ibn.fm/1PJhv). Gage Cannabis has sought to capitalize on surging cannabis demand within Michigan through its extensive distribution footprint – one which has seen the company establish a presence encompassing an estimated 90% of Michigan’s population within a one-hour radius of its dispensaries. The company’s initiatives have not gone unrewarded. Gage Cannabis recorded sales of $5.8 million in 1Q2020—a figure which rose to $11.9 million in 2Q2020 and is forecast to rise further to $13.1mn (unaudited) in 3Q2020 as per management guidance, marking a 129% growth in sales from 1Q2020 to 3Q2020. The increase has been reflected through a commensurate increase in the company’s cultivation capacity, which has risen from 200 pounds per month at the start of the year to an estimated 1,000 pounds by December – with the increase in cultivation capacity assisting the company promote rapid growth through its retail locations. A study carried out by the Brightfield Group found that the recreational marijuana market in Michigan could be set to rival the figures seen in areas such as Nevada and Colorado by 2023 (https://ibn.fm/VMNJ8). In fact, Michigan is already one of the top five cannabis markets based on the most recent month of cannabis sales. The study found that 3% of Michigan’s residents were medical marijuana cardholders, a figure which has led the consumer insights company to predict that the state’s recreational market could triple in size over the next three years. Gage Cannabis has recently announced its intentions to raise up to $50 million in gross proceeds through a regulation A+ offering (https://ibn.fm/wPg02), with a portion of the proceeds set to be re-invested to finance the company’s various growth initiatives. With Michigan’s cannabis market set to expand exponentially in the coming years, Gage Cannabis finds itself well-positioned to capitalize on market’s future growth trajectory. To learn more about the company’s Regulation A financing, visit www.GageInvestors.com. For more information on Gage Cannabis Co., visit the company’s website at www.GageUSA.com. NOTE TO INVESTORS: The latest news and updates relating to Gage Cannabis are available in the company’s newsroom at https://ibn.fm/GAGE

• SGTM completes two-year audit in preparation for upcoming SEC Form-10 filing
• Company targets fully reporting status, NASDAQ tier listing
• Subsidiary to supply mulch products, services to Midwest, Western New York 7-Eleven stores

Sustainable Green Team (OTC: SGTM), a leading provider of environmentally beneficial solutions for tree and storm waste disposal, has completed a two-year (2018 and 2019) audit in preparation for its upcoming SEC Form-10 filing (https://ibn.fm/uTDvF). The filing is part of SGTM’s strategic plan to become fully reporting and apply for uplisting.

“I’m truly blessed and proud of my team not only to complete our first two-year audit but to witness our catapult achievement,” said SGTM CEO and director Tony Raynor. “It’s thanks to my team and partners we have been able to achieve so much and progress with continue growth. Now with our audit complete, we are able to take our next major step on taking SGTM fully reporting and work our way to ultimately achieving NASDAQ tier listing.

“We are currently in discussion with multiple SEC legal counsel firms to see whom would fit best with our team and assist us on not only achieving every step along the way to be listed on the NASDAQ but to assure that we stay complaint with the SEC to provide transparency to our shareholders,” Raynor continued. “We plan on uploading our September 2020 quarter early November and updating our shareholders on our FORM-10 process as we progress.”

SGTM reported that the completed audit totaled $2,084,725 in revenue and $103,343 gross profit for FY 2019, respectively, and $508,591 in revenue and ($9,609) in gross profit for FY 2018. The company also recorded $18,637,665 in revenue and $5,081,772 gross profit for its June 2020 six-month uploaded quarter, which represents a 794% increase in revenue and 4,817% increase in gross profit compared to 2019’s operations.

In other good news for the company, its wholly owned subsidiary Mulch Manufacturing Inc. received an order to supply mulch products and services to 7-Eleven stores located throughout the Midwest and Western New York (https://ibn.fm/b52yJ). The contract, which is the most recent in an impressive list of contracts Mulch has nailed down in the last several weeks, starts in 2021.

“Thanks to our VP of sales Paul Stolly, we continue to secure major international chain accounts to start 2021 strong, commencing with 7-Eleven Inc.’s Midwest U.S. and western New York locations,” noted Raynor. “This allows us to build brand integrity and supply for future expansion as we progress.”

Sustainable Green Team, through its subsidiaries, provides tree services, debris hauling and removal, biomass recycling, mulch manufacturing, packaging and sales. The company was established with the objective of providing a solution for the treatment and handling of tree debris that has historically been disposed of in landfills, creating an environmental burden and pressure on disposal sites around the nation. SGTM’s solutions are founded in sustainability, based on vertically integrated operations that begin with collecting tree debris through its tree services division and collection sites and then, through its processing division, recycling and using that tree debris as a feedstock that is manufactured into a variety of organic, attractive, next-generation mulch products that are packaged and sold to landscapers, installers and garden centers.

The Sustainable Green Team plans to expand its operations through a combination of organic growth and strategic acquisitions that are both accretive to earnings and positioned for rapid growth from the resulting synergistic opportunities identified. SGTM’s customers include governmental, residential and commercial clients.

To learn more about Sustainable Green Team Ltd., view the company’s investor presentation at https://ibn.fm/reoNg.

NOTE TO INVESTORS: The latest news and updates relating to SGTM are available in the company’s newsroom at http://ibn.fm/SGTM

• InsuraGuest Technologies, Inc. currently offers two products in the hospitality and small business sector, with the opportunity for further expansion in the future
• InsureThePeople is providing small business owners, entrepreneurs, and freelancers with custom-catered insurance options at affordable rates and flexible payment schedules
• Small enterprises make up 99% of the United States’ 28.7 million businesses
• The InsuraGuest Hospitality product is compatible with over 70 different property-management products spanning hotel and vacation rental properties

InsuraGuest Technologies (TSX.V: ISGI) (OTC: IGSTF) is revolutionizing the insurance experience with the launch of the business owner policy (“BOP”) portal, extending general liability coverages to small businesses – a vital sector of the United States economy. Using InsuraGuest Technologies’ proprietary insurtech platform, InsureThePeople can provide on-demand and affordable insurance products to small business owners and entrepreneurs through technological means.

Businesses with revenues up to $6 million per location and occupancies up to 35,000 square feet are eligible to join the platform, with a minimum annual premium of $250. InsuraGuest Technologies’ targeted clients have up to 20 employees with sales and TIV under $1 million. They are typically small in size, like startups, consultants, or home-based businesses.

The InsureThePeople platform helps make insurance for small business easy and affordable with flexible payment schedules. It offers custom-tailored policies for small business owners in over 130 class codes. Insurance companies use class codes to determine the degree and type of risk a business may incur. The types of coverage that InsuraGuest Technologies may provide a business with are:

• Property
• Business Income
• Equipment
• General Liability
• Employment Liability
• Business Auto
• Professional Liability
• Liquor Liability
• Cyber Risk
• Workers’ Comp

Any number of these could be beneficial across the realm of small businesses, including startups, retail, accountants, freelancers, and more. And with the U.S. economy increasingly shifting to a small-business model, the market opportunities for InsuraGuest’s platform are expanding significantly.

Additionally, the company’s insurtech and insurance offerings come at a time of change for the insurance industry, with established carriers working on adding new technologies to their current platforms. In 2019, $5.54 billion was invested in insurtech, a quarter of the amount coming from larger carriers (https://ibn.fm/FH8Ol). Over the last decade, close to $16.5 billion has been invested into insurtech, pressuring the market to change and become more innovative. As the market grows, InsuraGuest Technologies will continue to expand across different insurance industry sectors, not just hospitality and small business.

InsuraGuest Hospitality covers both hotels and vacation rental properties, and was designed to fill the gaps in other policies on the market, including a claims process that is easier to navigate. The company’s insurtech platform is compatible with approximately 70 different hotel property-management systems, which include Hilton-ONQ, Oracle Opera, Marriot Fosse, Agilysis, Springer-Miller Systems, Lightspeed GPS, and many others.

For more information about the company, please visit www.InsuraGuest.com.

NOTE TO INVESTORS: The latest news and updates relating to ISGI are available in the company’s newsroom at http://ibn.fm/ISGI

• 128 new artists signed up with FDBL’s Fan Pass
• Livestreaming platform meets need of artists seeking foundational elements of performing from virtual stage
• Fan Pass allows artists to offer exclusive content channels to fans, provides music lovers with all-access pass to all artists on platform

Friendable (OTC: FDBL) has announced that its new livestreaming artist platform, Fan Pass, added 128 new artists to its lineup from Oct. 12 through Oct. 27, a 35% increase in a short two-week period (https://ibn.fm/enG6i). Fan Pass, FDBL’s flagship product, supports musical artists at all levels by providing exclusive artist-content channels, livestreaming events, promotional support, fan subscriptions and custom merchandise designs, all of which serve as revenue streams for each artist.

“As the uncertainty continues around live venues and performances, we feel even stronger demand from artists seeking the foundational elements of performing from the virtual stage,” said Friendable CEO Robert A. Rositano Jr. “No matter how the limitations of performing in front of an in-person audience shakes out, Fan Pass is here to build relationships with artists, labels and their fan communities so we can support reentry to these in person performances, while creating a ‘hybrid’ model of virtual performances for fans around the world.”

The addition of new artists brings the Fan Pass roster up to more than 500 artists total who have signed onto the platform since the app’s July 2020 launch. Recognizing the power of this new platform, artists around the world are likely to seize the opportunity to connect with fans everywhere — and make money while doing so.

Friendable is a mobile technology and marketing company focused on connecting and engaging users through its proprietary mobile and desktop applications. Launched July 24, 2020, Fan Pass is designed to help artists engage with their fans around the world and earn revenue while doing so. The livestreaming platform allows artists to offer exclusive content channels to their fans, who can use their smartphones to gain access to their favorite artists as well as an all-access pass, giving them access to all artists on the platform.

Additionally, the Fan Pass team will deploy social broadcasters to capture exclusive VIP experiences, interviews and behind-the-scenes content featuring their favorite artists, all available to fan subscribers for free on a trial basis. Following the trial period, subscriptions are billed monthly at $3.99, or about the cost of downloading a couple of songs, providing VIP access at a fraction of the cost of traditional face-to-face meetups.

For more information about Friendable or the Fan Pass platform, services and offering, visit the company’s website at www.Friendable.com or www.FanPassLive.com.

NOTE TO INVESTORS: The latest news and updates relating to FDBL are available in the company’s newsroom at http://ibn.fm/FDBL

• Predictive Oncology CEO Carl Schwartz featured on NNW’s podcast to discuss the company’s prospects
• Schwartz elaborated on company’s various divisions, affirming that POAI had begun to see revenue trends stabilize, cash burn rates decline
• TumorGenesis received overwhelmingly positive feedback on its initial product launches, with plans to extend its technological prowess to address other oncological segments
• Soluble Biotech, which announced its first major contract in August, is expected to reveal news of second order win in near future
• Schwartz touched upon POAI’s Helomics business, stating his belief that division could soon transition towards monetizing its unique and one-of-a-kind asset portfolio

Predictive Oncology (NASDAQ: POAI) CEO Carl Schwartz was recently featured in an exclusive audio interview with NetworkNewsWire (“NNW”), a financial news and content distribution company, to provide an update on the company’s recent milestones and near-term goals following the October release of his open letter to Predictive Oncology’s shareholders (https://ibn.fm/XLY14). During the wide-ranging conversation, Schwartz sought to update listeners on the company’s subsidiaries – Skyline Medical, TumorGenesis, Soluble Biotech and Helomics (https://ibn.fm/Vqkh5).

Schwartz commenced by outlining the status of the company’s Skyline Medical business, charged with overseeing the manufacture and sale of their proprietary STREAMWAY system – designed to provide medical facilities with a direct-to-drain fluid disposal system. The CEO revealed that although the company had sought to reduce emphasis on its legacy division, the company had sold 18 STREAMWAY units thus far in 2020 with the expectation of selling between 5-7 more over the course of the year.

Moreover, he explained that the business was throwing off an estimated $700 thousand in annual free cash-flows—a figure which has proven to be more than sufficient to cover the unit’s operating expenses.

Schwartz went on to elaborate on the TumorGenesis business, which specializes in the field of ovarian cancer, creating laboratory-grown cancer cells which can then be used to assist researchers and clinicians identify which cancer cells bind to specific biomarkers. He revealed that the company had received overwhelmingly positive feedback in regards to the division’s initial product launch and stated that the company would seek to extend its technological prowess towards addressing oncological segments such as lung cancer in the future.

The interview later transitioned to POAI’s most recent acquisition, Soluble Biotech, which seeks to provide optimized FDA-approved formulations for vaccines, antibodies and other protein therapeutics in a faster and lower cost basis to its customers. In August 2020, the company announced its first contract with a major pharmaceutical company for protein expression and solubility studies, and Schwartz stated that a second significant contract would be announced in the near future. Going forward, the CEO expressed his optimism on further contract wins as well as the award of certain grants, which had been applied for by the division.

Schwartz also touched upon Predictive Oncology’s outlook for the fourth quarter – placing particular emphasis on the prospects of the company’s Helomics business. Through its Helomics division, the company leverages its unique, clinically validated patient derived (“PDx”) smart tumor profiling platform to provide oncologists with a roadmap to help individualize therapy. In addition, the company is leveraging artificial intelligence and its proprietary database of over 150,000 cancer case tumors to build AI-driven models of tumor drug response with the hope of improving outcomes for the patients of today and tomorrow.  With the wealth of knowledge and experience gleaned over its operational lifespan, Schwartz affirmed his belief that Helomics was well on its way towards monetizing its exceptional and one-of-a-kind asset portfolio and validating the ambitions that POAI had harbored for the division upon its purchase a little over two years ago.

For more information, visit the company’s website at www.Predictive-Oncology.com.

NOTE TO INVESTORS: The latest news and updates relating to POAI are available in the company’s newsroom at http://ibn.fm/POAI